Exhibit 99.1

FOR IMMEDIATE RELEASE

October 27, 2014

Owens & Minor Reports Financial Results for 3^rd Quarter 2014

RICHMOND, VA….Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the third quarter ended September 30, 2014, including the following highlights:

For the quarter ended September 30, 2014, the company reported consolidated revenues of $2.39 billion, improved 5.1% over revenues in the third quarter of 2013. Quarterly net income was $7.2 million, or $0.11 per diluted share. Adjusted net income (non-GAAP) was $26.5 million, or $0.42 per diluted share, which excluded the following after-tax charges: $3.6 million for acquisition-related and $6.7 million for exit and realignment activities, as well as $9.1 million for the loss on early retirement of debt due to the company’s balance sheet recapitalization.

“We are very pleased with the strong growth we are seeing in our top line, which we believe is a result of our strategic approach to the market, as well as the improving healthcare environment,” said James L. Bierman, president & chief executive officer of Owens & Minor. “In the coming months, we will be fully engaged with the integration of the previously announced Medical Action acquisition, as well as the pending ArcRoyal acquisition. We are enthusiastic about the new and broader capabilities that these transactions will enable us to bring to our customers.”

Consolidated operating earnings for the third quarter of 2014 were $35.4 million, a decline of $13.8 million, when compared to the third quarter last year. Adjusted consolidated operating earnings (non-GAAP) for the third quarter of 2014 were $49.3 million, or 2.07% of revenues, a decline of $2.6 million when compared to the same period last year.

Third quarter 2014 results also included $0.9 million of additional interest expense from the balance sheet recapitalization, which reduced adjusted net income by approximately $0.01 per diluted share. In addition, third quarter results reflected the impact of International segment exit and realignment costs on foreign taxes, as well as certain non-deductible acquisition expenses. These factors increased the company’s effective tax rate for the quarter to 55.8%, reducing adjusted net income by approximately $0.01 per diluted share.

Year-to-Date Results

For the nine months ended September 30, 2014, consolidated revenues were $6.95 billion, increased approximately $195.4 million, or 2.9%, when compared to consolidated revenues for the same period of 2013. Net income for the period was $52.5 million, or $0.84 per diluted share. Adjusted net income

1

(non-GAAP) was $79.2 million, or $1.26 per diluted share, excluding after-tax charges of: $6.6 million for acquisition-related activities, $11.0 million for exit and realignment activities, and the $9.1 million loss on early retirement of debt. Year-to-date results include the first quarter recovery of $5.3 million from the settlement of a direct purchaser anti-trust class action lawsuit, which was included in other operating income.

Consolidated operating earnings for the year-to-date period of 2014 were $118.8 million, or 1.71% of revenues. Adjusted consolidated operating earnings (non-GAAP) for the year-to-date period were $143.6 million, or 2.07% of revenues, compared to $152.5 million, or 2.26% of revenues, for the same period last year.

The year-to-date tax rate increased to 43.5%, as a result of the factors that affected the third quarter tax rate.

Acquisitions Update

Effective October 1, 2014, Owens & Minor completed the acquisition of Medical Action Industries, Inc. and immediately launched a comprehensive integration plan. During the third quarter of 2014, Owens & Minor announced plans to acquire privately held ArcRoyal, a surgical kitting company based in Ireland, and expects the transaction will close during the fourth quarter of 2014. Together, these two transactions provide Owens & Minor with capabilities that are highly complementary to its strategic goals for developing unitized delivery services for the healthcare industry. Due to the timing of these two transactions, Owens & Minor does not expect the acquisitions to make a material contribution to operational results in the fourth quarter of 2014.

Balance Sheet Recapitalization

During the quarter, Owens & Minor issued $275 million of 3.875% Senior Notes due 2021 and $275 million of 4.375% Senior Notes due 2024. As part of the recapitalization, the company accrued a $14.9 million pre-tax loss on the early retirement of its 2016 Senior Notes. Also during the third quarter, Owens & Minor amended its existing Credit Agreement (dated June 12, 2012), increasing the borrowing capacity to $450 million and extending the term to 2019.

In the fourth quarter, proceeds of approximately $446 million were used to purchase the outstanding shares of Medical Action Industries on October 1, 2014, and to fund the early retirement of the company’s 2016 Senior Notes on October 16, 2014.

Asset Management

The balance of cash and cash equivalents was $610 million at September 30, 2014, reflecting the company’s balance sheet recapitalization. As noted above, the cash balance was reduced in the fourth quarter of 2014 by redemption of the 2016 Senior Notes and completion of the Medical Action Industries transaction. For the first nine months of 2014, the company reported cash provided by operating activities of $81 million. Asset management metrics for the quarter were positive with consolidated days sales outstanding (DSO) of 21.8 days as of September 30, 2014, and consolidated inventory turns of 10.0 for the third quarter of 2014.

Segment Results

Domestic segment revenues for the third quarter of 2014 were $2.26 billion, an increase of $86.4 million, or 4.0%, when compared to the prior year’s third quarter revenues of $2.18 billion. For the year-to-date period, Domestic segment revenues were $6.60 billion, improved $124.5 million, or 1.9% when

2

compared to revenues of $6.47 billion for the same period last year. In both the quarterly and year-to-date periods, revenue gains resulted primarily from growth among larger healthcare provider customer accounts.

For the third quarter of 2014, Domestic segment operating earnings were $50.8 million, or 2.25% of segment revenues, essentially unchanged when compared to the same period of 2013. The quarterly results were negatively affected by increases in legal expenses. For the year-to-date period, Domestic segment operating earnings declined $3.5 million to $151.8 million, or 2.30% of segment revenues, when compared to the prior year period. For the year-to-date period, the decline resulted from lower benefits from manufacturer product price changes and increased legal expenses, as well as lower margin on new and renewed customer contracts. These negative factors were offset by cost benefits realized from ongoing strategic initiatives focused on achieving gains in productivity and efficiency.

The International segment contributed revenues of $124.0 million, improved 30.7%, for the third quarter of 2014 and had an operating loss of $1.5 million, when compared to the same period last year. However, on a sequential basis, quarterly operating losses for the International segment and the U.K. division were reduced by more than 50%, as a result of significant remediation efforts. For the year-to-date period, the International segment reported $349.8 million in revenues, improved 25.4%, along with year-to-date operating losses of $8.3 million. For the year-to-date period, the company attributed the International segment operating losses to operations in the United Kingdom, including a combination of increased costs associated with integrating a significant new customer and reduced customer activity.

Highlights & Upcoming Events

Investors Conference Call & Supplemental Material

Owens & Minor’s management team will conduct a conference call to discuss the third quarter financial results on Tuesday, October 28, at 8:30 a.m. EST. The access code for this event is #20117288. The dial-in number for the live conference call is 866-393-1604; the international dial-in number is 224-357-2191; a replay of the call will be available for one week by calling 855-859-2056. A webcast of the event, along with supplemental financial information, will be available on www.owens-minor.com under the Investor Relations section.

Owens & Minor uses its website, www.owens-minor.com, as a channel of distribution for material company information, including news releases, investor presentations and financial information. This information is routinely posted and accessible under the Investor Relations section.

3

Included with the press release financial tables are reconciliations of the differences between the non-GAAP financial measures presented in this news release, which exclude acquisition-related, exit and realignment charges, and the loss on early retirement of debt, and their most directly comparable GAAP financial measures.

Safe Harbor Statement

Except for historical information, the matters discussed in this press release may constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected. These risk factors are discussed in reports filed by the company with the Securities & Exchange Commission. All of this information is available at www.owens-minor.com. The company assumes no obligation, and expressly disclaims any such obligation, to update or alter information, whether as a result of new information, future events, or otherwise.

Owens & Minor, Inc. (NYSE: OMI) is a leading healthcare logistics company dedicated to Connecting the World of Medical Products to the Point of Care^TM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor’s customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, and the federal government. A FORTUNE 500 company, Owens & Minor is headquartered in Richmond, Virginia, and has annualized revenues exceeding $9 billion. For more information about Owens & Minor, visit the company website at owens-minor.com.

CONTACTS:

Trudi Allcott, Director, Investor & Media Relations, 804-723-7555; truitt.allcott@owens-minor.com

Chuck Graves, Director, Finance & Investor Relations, 804-723-7556; chuck.graves@owens-minor.com

Source: Owens & Minor

4

Owens & Minor, Inc.

Consolidated Statements of Income (unaudited)

(in thousands, except per share data)

Page 5

Owens & Minor, Inc.

Condensed Consolidated Balance Sheets (unaudited)

(in thousands)

Page 6

Owens & Minor, Inc.

Consolidated Statements of Cash Flows (unaudited)

(in thousands)

Page 7

Owens & Minor, Inc.

Financial Statistics and GAAP/Non-GAAP Reconciliations (unaudited)

Use of Non-GAAP Measures

This earnings release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). In general, the measures exclude items and charges that (i) management does not believe reflect Owens & Minor, Inc.’s (the “Company”) core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred over multiple or in prior periods without predictable trends. Management uses these non-GAAP financial measures internally to evaluate the Company’s performance, evaluate the balance sheet, engage in financial and operational planning and determine incentive compensation.

Management provides these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on its financial and operating results and in comparing the Company’s performance to that of its competitors. However, the non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.

The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth above should be carefully evaluated.

Page 8

Owens & Minor, Inc.

Summary Segment Information (unaudited)

(in thousands)

Page 9

Owens & Minor, Inc.

Summary Segment Information (unaudited)

(in thousands)

Page 10

Owens & Minor, Inc.

Net Income Per Common Share (unaudited)

(in thousands, except per share data)

Page 11